2,254
Views
120
CrossRef citations to date
0
Altmetric
REVIEWS

Polymeric Membranes for Chiral Separation of Pharmaceuticals and Chemicals

, , , , , , , & show all
Pages 113-143 | Received 10 Dec 2009, Accepted 11 Jan 2010, Published online: 19 Apr 2010
 

Abstract

The optical resolution or chiral separation of one specific enantiomer from others is in demand for the production of pharmaceuticals because many pharmaceuticals exist as stereoisomers, with each enantiomer having different biological activity. There is considerable demand for separation techniques appropriate for the large-scale resolution of chiral molecules. Chiral separation of racemic mixtures of pharmaceuticals through chiral or achiral polymeric membranes with or without a chiral selector represents a promising system for future commercial application. This article reviews several polymeric materials for the chiral separation of pharmaceuticals. Several chiral separation membranes were prepared from chiral polymers where enantioselectivity was generated from chiral carbons in the main chain. However, it is rather difficult to generate excellent chiral separation membranes from chiral polymers alone, because racemic penetrants mainly encounter the flexible side chains of the membrane polymers. Therefore, chiral separation membranes were also prepared using polymers with a chiral branch. Furthermore, several molecules have been used for specific interactions between the molecules and specific pharmaceuticals or drugs in chiral separation membranes. Cyclodextrins, crown ether derivatives, albumin, and DNA are commonly used as stereoselective ligands in chiral separation membranes. Finally, this article discusses future trends in polymeric materials for chiral separation membranes.

Notes

aPoly(OPSPA); Poly(p-(oligopinanylsiloxanyl)phenylacetylene), Poly(CPSPA); Poly(chiral pinanylsiloxanyl)phenylacetylene), Poly(HPSPA); Poly(hydroxylpinanylsiloxanyl)phenylacetylene), Copoly(CHPSPA); Copoly(chiral hydroxylpinanylsiloxanyl)phenylacetylene), Copoly(PSDPA); Copoly(pinanylsilyl)diphenylacetylene), MTSPOE; 1,2-bis(2-methyl-1-triethylsiloxy-1-propeny loxy)ethane derivatives.

bMethod; D indicates dialysis, UF indicates ultrafiltration.

aPoly(DPSPP); Poly[(−)-1-p-[dimethyl(10-pinanyl)silyl]phenyl-2-phenylacetylene], Poly(DPSP); Poly{1-dimethyl(10-pinanyl)sily]-1-propyne}, PAN-g-D-glucitol; Polyacrylonitrile-graft-(1->6)-2,5-anhydro-D-glucitol, PMLG; Poly(L-glutamate), PSf; Polysulfone.

bMethod; D indicates dialysis, ED indicates electro dialysis, PV indicates pervaporation, UF indicates ultrafiltration.

aBSA; bovine serum albumin.

bMethod; D indicates dialysis, UF indicates ultrafiltration.

aMethod; D indicates dialysis,. ED indicates electro dialysis, UF indicates ultrafiltration.

aCopoly(HPA); copoly(hydroxylphenylacetylene), Poly(HPA); Poly(hydroxylphenylacetylene).

bMethod; N indicates nanofiltration, and D indicates dialysis.

aPotential-driven permeation

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.